Skip to main content
. 2021 Oct 19;12(2):41–43. doi: 10.4103/2045-9912.325990

Figure 1.

Figure 1

Various beneficial properties of melatonin when used in COVID-19 patients.

Note: COVID-19: Coronavirus disease 2019; IFN-λ: interferon-λ; IL-6: interleukin-6; SARS-CoV2: severe acute respiratory syndrome coronavirus 2; TNF-α: tumor necrosis factor-α.